Figure 1. Inducible expression of degradation-domain (DD)-tagged mutants of PFK2/FBPase2 in pancreatic islets.
(A) Schematic of DD-tagged mutants of PFK2/FBPase2. (B and C) Western blots of islets transduced with DD-PFK2 and DD-FBPase2 truncations mutants (B), or DD-tagged phosphatase-dead PFK2/FBPase2 (DD-H259A) and kinase-dead PFK2/FBPase2 (DD-T55V) point mutants (C), treated with either vehicle (0.1% DMSO) or 1 µM Shield1, and visualized with an anti-DD antibody. Representative of three independent experiments (50 islets per treatment).